Kyverna Therapeutics, Inc. (Kyverna, NASDAQ: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, announced that the Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback